New insights into mast cell activation syndrome (MCAS) have emerged with the six-year update on the global consensus-2 diagnostic criteria. This progress aims to enhance diagnostic accuracy and patient management for those affected by this rare condition.
progress in mast cell activation syndrome the global consensus 2 diagnostic criteria at six years
Original title: “Progress in mast cell activation syndrome: the global consensus-2 diagnostic criteria at six years.”